Scientific researchers have found that a dose of Magic Mushrooms had a big effect on cancer patients and a single dose of psilocybin in a controlled setting appears to reap long-term benefits.

Psilocybin is a serotonin receptor agonist that occurs naturally in some mushroom species. Recent studies have assessed the therapeutic potential of psilocybin for various conditions, including end-of-life anxiety,obsessive-compulsive disorder, and smoking and alcohol dependence, with promising preliminary results. Researchers aimed to investigate the feasibility, safety, and efficacy of psilocybin in patients with unipolar treatment-resistant depression.

Magic mushroom drug helps people with cancer face death

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

A Dose of a Hallucinogen From a ‘Magic Mushroom,’ and Then Lasting Peace

Magic mushrooms lift severe depression in clinical trial

Psilocybin with psychological support for treatment-resistant
depression: an open-label feasibility study

Magic-mushroom drug lifts depression in first human trial


Hallucinogenic Mushrooms

Psilocybin, from hallucinogenic mushrooms, greatly reduces anxiety in cancer patients

Magic Mushrooms

Mind-altering mushroom drug lifted "cloud of doom" for cancer patients, study finds